Related Experiment Videos

New diagnostic devices in heart failure

Kelly H Schlendorf1, Stuart D Russell

  • 1Division of Cardiology, Department of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA.

Current Opinion in Cardiology
|March 24, 2010
PubMed

Insights

Emerging implantable devices can predict heart failure events by monitoring hemodynamic values and intrathoracic impedance. These technologies show promise for reducing heart failure hospitalizations and improving patient outcomes.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Heart failure is a major cause of illness and death in the US.
  • Implantable devices are being developed to predict heart failure decompensation.
  • Early detection aims to prevent clinical decline.

Purpose of the Study:

  • Review emerging implantable diagnostic devices for heart failure.
  • Discuss their implications for future heart failure management.
  • Highlight their potential to reduce morbidity and mortality.

Main Methods:

  • Review of recent studies on implantable heart failure devices.
  • Analysis of devices measuring hemodynamic values (pulmonary/left atrial pressures).
  • Evaluation of devices assessing intrathoracic impedance for pulmonary congestion.

Main Results:

  • Device-acquired parameters correlate well with pulmonary artery catheterization data.
  • Some trials suggest a reduction in heart failure events with pressure-monitoring devices.
  • Ongoing trials are investigating the impact on heart failure outcomes.

Conclusions:

  • Diagnostic devices may significantly aid heart failure patient management.
  • These technologies have the potential to reduce patient and healthcare system burdens.
  • Future research will further elucidate their role in improving heart failure care.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...